Frederic Kaye
Overview
Explore the profile of Frederic Kaye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
608
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stewart B, Kaye F, Machuca T, Mehta H, Mohammed T, Newsom K, et al.
Int J Surg Pathol
. 2019 Aug;
28(1):102-108.
PMID: 31382829
SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a recently described entity with a poor prognosis that is defined by certain genetic alterations in the BAF chromatin remodeling complex, specifically and . We...
2.
Biswas A, Jiang Y, Li D, Mehta H, Kaye F
Front Oncol
. 2018 Sep;
8:358.
PMID: 30250826
A higher incidence of Rhesus group D (RHD)-negative blood group among patients with Small Cell Cancer of the lung (SCLC) had been previously reported but reproducibility was not confirmed, and...
3.
Lee H, Mohammed K, Goldberg E, Kaye F, Najmunnisa N
Cancer Invest
. 2016 Jul;
34(7):293-304.
PMID: 27438907
Receptor EphA2 is overexpressed in lung cancer and malignant pleural mesothelioma (MPM) which promote tumorogenesis. Lipoplatin™, a new liposomal cisplatin formulation, is used against resistant tumors. Use of cisplatin-based drugs...
4.
Lee H, Mohammed K, Goldberg E, Kaye F, Nasreen N
Am J Cancer Res
. 2015 May;
5(2):603-15.
PMID: 25973300
The low solubility of cisplatin in aqueous solution limits the treatment effectiveness and the application of cisplatin in various kinds of drug-eluting devices. Although cisplatin has a high solubility in...
5.
Salz T, Li G, Kaye F, Zhou L, Qiu Y, Huang S
Cancer Res
. 2013 Nov;
74(3):775-86.
PMID: 24247718
hSETD1A is a member of the trithorax (TrxG) family of histone methyltransferases (HMT) that methylate H3K4 at promoters of active genes. Although misregulation of mixed lineage leukemia (MLL) family proteins...
6.
Sukka-Ganesh B, Mohammed K, Kaye F, Goldberg E, Nasreen N
BMC Cancer
. 2012 Jul;
12:309.
PMID: 22824143
Background: Tumor formation is a complex process which involves constitutive activation of oncogenes and suppression of tumor suppressor genes. Receptor EphA2 and its ligand ephrin-A1 form an important cell communication...
7.
Thomas R, Baker A, DeBiasi R, Winckler W, LaFramboise T, Lin W, et al.
Nat Genet
. 2007 Feb;
39(3):347-51.
PMID: 17293865
Systematic efforts are underway to decipher the genetic changes associated with tumor initiation and progression. However, widespread clinical application of this information is hampered by an inability to identify critical...
8.
Chute J, Taylor E, Williams J, Kaye F, Venzon D, Johnson B
Clin Cancer Res
. 2006 Feb;
12(3 Pt 1):888-96.
PMID: 16467103
Purpose: One-third of patients with lung cancer and hyponatremia have no evidence of ectopic arginine vasopressin (AVP) production and the cause of their hyponatremia is not conclusively established. We sought...
9.
Means-Markwell M, Linnoila R, Williams J, Janne P, Kaye F, ONeil K, et al.
Clin Cancer Res
. 2003 Dec;
9(16 Pt 1):5915-21.
PMID: 14676115
Purpose: We conducted our study to compare the number of preneoplastic lesions in the airways and nodules in the pulmonary parenchyma of patients with resected non-small cell lung cancer with...